Newsbenzinga
Boston Scientific Lowers FY2026 Adj EPS Guidance from $3.34-$3.41 to $3.28-$3.32 vs $3.36 Est; Lowers FY2026 Sales Guidance from $21.479B-$21.780B to $21.178B-$21.379B vs $21.562B Est
· Published
Article summary
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…